Business
CardioComm Solutions SMART Monitoring ECG Software to Interface with Cardiac Sensing Wearable Devices for Smartphone Connected Medical-Wellness Markets
TORONTO, ON / ACCESSWIRE / June 20, 2016 / CardioComm Solutions, Inc. (TSXV: EKG) ("CardioCo...
About this update from Cardiocomm Solutions, Inc.
[{"type":"text","content":"CardioComm Solutions SMART Monitoring ECG Software to Interface with Cardiac Sensing Wearable Devices for Smartphone Connected Medical-Wellness MarketsTORONTO, ON / ACCESSWIRE / June 20, 2016 / CardioComm Solutions, Inc. (TSXV: EKG) (\"CardioComm Solutions\" or the \"Company\"), a global medical provider of consumer heart monitoring and medical electrocardiogram (\"ECG\") software solutions, today confirms it is qualifying devices from multiple manufacturers with the aim to bring to market new Smartphone connected health and cardiac monitoring technologies. CardioComm Solutions approved devices will be supported by the CardioComm Solutions' SMART Monitoring ECG reading and GEMS™ WIN for use by consumers, physicians and hospital systems.\nCardioComm Solutions has pre-qualified several devices of interest and expects pending sales and marketing agreements with manufacturers to be executed in 2016. When testing and integration is completed, the Company intends to apply for and secure Class II medical device clearances for sales of the devices in the USA and Canada under the HeartCheck™ brand. The Company will hold exclusive rights for the sale of the HeartCheck™ branded devices in North America. In turn, the integrated devices would be permitted to be distributed through the original devices' manufacturer's distribution networks under their own OEM agreements and brands in overseas markets while promoting connectivity to the CardioComm Solutions' ECG management software and ECG reading services. Multiple revenue streams for CardioComm Solutions will be created through direct sales from HeartCheck™ branded devices, a percentage of device sales from device manufacturer OEM sales overseas, and recurrent revenue generated through software licensing or fee-for-service use of the SMART Monitoring ECG reading service from all devices sold.\nWhile large wellness product companies continue to try and out-compete each other by adding more and more built in sensor technologies to monitor wellness, sleep and activity, and consumers look for more credible health monitoring, there are no clear signs that these companies will seek medical device clearances for their devices. The CardioComm Solutions announcement signals that this may soon change.\nCardioComm Solutions' strategy is to focus on its established medical so...